BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta S, Mullish BH, Allegretti JR. Fecal Microbiota Transplantation: The Evolving Risk Landscape. Am J Gastroenterol 2021;116:647-56. [PMID: 33982930 DOI: 10.14309/ajg.0000000000001075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Houf J. Faecal microbiota transplants: towards a healthy disgust scepticism. Med Humanit 2021;47:407-16. [PMID: 34509994 DOI: 10.1136/medhum-2020-012135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Smith DR, Temime L, Opatowski L. Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control. Elife 2021;10:e68764. [PMID: 34517942 DOI: 10.7554/eLife.68764] [Reference Citation Analysis]
3 Wang H, Yang F, Zhang S, Xin R, Sun Y. Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via fecal microbiota transplantation. NPJ Parkinsons Dis 2021;7:70. [PMID: 34381040 DOI: 10.1038/s41531-021-00213-7] [Reference Citation Analysis]
4 Foster JA, Baker GB, Dursun SM. The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder. Front Neurol 2021;12:721126. [PMID: 34650506 DOI: 10.3389/fneur.2021.721126] [Reference Citation Analysis]
5 Nicholson MR, Hourigan SK, Conrad M, Goyal A, Jensen K, Kelsen J, Kennedy M, Weatherly M, Kahn SA. Current Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. Am J Gastroenterol 2021;116:1954-6. [PMID: 34140459 DOI: 10.14309/ajg.0000000000001350] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Stojek M, Jabłońska A, Adrych K. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med 2021;10:4055. [PMID: 34575166 DOI: 10.3390/jcm10184055] [Reference Citation Analysis]
7 Su X, Yao B. Exploiting enzymes as a powerful tool to modulate the gut microbiota. Trends Microbiol 2022:S0966-842X(22)00003-8. [PMID: 35120774 DOI: 10.1016/j.tim.2022.01.003] [Reference Citation Analysis]
8 Brauer M, Herrmann J, Zühlke D, Müller R, Riedel K, Sievers S. Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis. Gut Pathog 2022;14:4. [PMID: 34991700 DOI: 10.1186/s13099-021-00475-9] [Reference Citation Analysis]
9 Al-Nesf MA, Morgan D, Mohamed-Ali V. Primary immunodeficiency and the microbiome. Curr Opin Pediatr 2021;33:633-8. [PMID: 34654047 DOI: 10.1097/MOP.0000000000001067] [Reference Citation Analysis]